Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
Latest
Popular

Ibrutinib plus venetoclax for first-line treatment of chronic lymphocytic leukaemia

Dr William Wierda - University of Texas MD Anderson Cancer Center, Houston, USA
Ibrutinib plus venetoclax for first-line treatment of chronic lymphocytic leukaemia ( Dr William Wierda - University of Texas MD Anderson Cancer Center, Houston, USA )
5 Dec 2020

PARP inhibitors in prostate cancer: A promise delivered

Dr Abhishek Tripathi - Stephenson Cancer Center, Oklahoma City, USA
PARP inhibitors in prostate cancer: A promise delivered ( Dr Abhishek Tripathi - Stephenson Cancer Center, Oklahoma City, USA )
1 Dec 2020

Targeting a KRAS neoantigen peptide vaccine to DNGR-1 dendritic cells

Dr Rachel Ambler - The Francis Crick Institute, London, United Kingdom
Targeting a KRAS neoantigen peptide vaccine to DNGR-1 dendritic cells ( Dr Rachel Ambler - The Francis Crick Institute, London, United Kingdom )
27 Nov 2020

OncoAlert and ecancer weekly roundup for November 15 - 21, 2020

Dr Gil Morgan - Skåne University Hospital in Lund, Sweden
OncoAlert and ecancer weekly roundup for November 15 - 21, 2020 ( Dr Gil Morgan - Skåne University Hospital in Lund, Sweden )
27 Nov 2020

Clinical genomic testing in prostate cancer

Laurie M Connors - Vanderbilt University School of Nursing, Nashville, USA
Clinical genomic testing in prostate cancer ( Laurie M Connors - Vanderbilt University School of Nursing, Nashville, USA )
24 Nov 2020

PARP inhibitors for prostate cancer - Nurse's view

Laurie M. Connors - Vanderbilt University School of Nursing, Nashville, USA
PARP inhibitors for prostate cancer - Nurse's view ( Laurie M. Connors - Vanderbilt University School of Nursing, Nashville, USA )
24 Nov 2020

Predictors of efficacy in patients with HR positive/HER2 negative ABC: Subgroup analyses of PALOMA-3

Prof Hope Rugo - University of California, San Francisco, USA
Predictors of efficacy in patients with HR positive/HER2 negative ABC: Subgroup analyses of PALOMA-3 ( Prof Hope Rugo - University of California, San Francisco, USA )
23 Nov 2020

OncoAlert and ecancer weekly roundup for November 8 - 14, 2020

Dr Gil Morgan - Skåne University Hospital in Lund, Sweden
OncoAlert and ecancer weekly roundup for November 8 - 14, 2020 ( Dr Gil Morgan - Skåne University Hospital in Lund, Sweden )
17 Nov 2020

Interim results from a phase 1/2 precision medicine study of PLX8394- a next generation BRAF inhibitor

Dr Filip Janku - The University of Texas MD Anderson Cancer Center USA
Interim results from a phase 1/2 precision medicine study of PLX8394- a next generation BRAF inhibitor ( Dr Filip Janku - The University of Texas MD Anderson Cancer Center USA )
17 Nov 2020

OncoAlert and ecancer weekly roundup for November 2 - 7, 2020

Dr Gil Morgan - Skåne University Hospital, Lund, Sweden
OncoAlert and ecancer weekly roundup for November 2 - 7, 2020 ( Dr Gil Morgan - Skåne University Hospital, Lund, Sweden )
9 Nov 2020

SAFIR 02: Durvalumab compared to maintenance chemotherapy for metastatic non-small cell lung cancer

Prof Fabrice Barlesi - Gustave Roussy, Villejuif, France
SAFIR 02: Durvalumab compared to maintenance chemotherapy for metastatic non-small cell lung cancer ( Prof Fabrice Barlesi - Gustave Roussy, Villejuif, France )
6 Nov 2020

PIONeeR: Understanding PD-L1 resistances in non-small cell lung cancer

Prof Fabrice Barlesi - Gustave Roussy, Villejuif, France
PIONeeR: Understanding PD-L1 resistances in non-small cell lung cancer ( Prof Fabrice Barlesi - Gustave Roussy, Villejuif, France )
6 Nov 2020

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation